Beroni Logo @ Dec 2019.png
Beroni Group Announced the Latest Clinical Study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)
August 31, 2021 08:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced the latest clinical...
researchdrivelogo.jpg
Increasing Cases of Coronavirus Infection around the World to Propel the Growth of Global COVID-19 Diagnostics Market – Exclusive Report [410 Pages] By Research Dive
August 18, 2021 09:04 ET | Research Dive
New York, USA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global covid-19 diagnostics market is expected to generate a revenue of $65,750.1 million by...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.
March 12, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Logo.png
GTX Corp Adds Rapid Diagnostic Test Kits for the SARS-COV-2 (COVID-19) Antigen
February 18, 2021 08:35 ET | GTX Corp
LOS ANGELES, CALIFORNIA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS human and asset tracking systems and a supplier of...
Achiko Logo cropped.jpg
Achiko Establishes Joint Venture with PT Indonesia Farma Medis for Production and Distribution of its Test Platform for Covid-19 in Indonesia
February 12, 2021 07:30 ET | Achiko AG
Achiko Signs Agreement with PT Indonesia Farma Medis to Establish a New Joint Venture, including a Contract with PT Mitra Asa Pratama and a Memorandum of Understanding with PT Pharos Indonesia,...
Achiko Logo cropped.jpg
Achiko Strengthens Leadership Team with New President and New SVP Commercialization
January 11, 2021 07:30 ET | Achiko AG
Appoints New President, Biotechnology Research Scientist and Entrepreneur Dr. Morris S. Berrie Appoints New SVP Commercialization, Business Leader in Life Science Richard Lingard New Senior Leadership...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen
December 30, 2020 12:48 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that a Marketing Authorization Application has been submitted by its agents in...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Receives Licensure From the State of California for Clinical Testing Laboratory (CLIA) Allowing for Clinical Sample Testing
December 08, 2020 20:06 ET | Sorrento Therapeutics, Inc.
Sorrento receives Clinical Laboratory Improvement Amendments (CLIA) license from the State of California for clinical sample testingSorrento intends to initially offer three diagnostic tests for...
Achiko Logo cropped.jpg
Achiko Secures Convertible Loan Facility with Yorkville Advisors of USD $2.5 Million, with a Provisional Extension of Up to USD $9.5 Million
November 26, 2020 07:00 ET | Achiko AG
ZURICH, Switzerland, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) announces the completion of a convertible loan facility with US based fund manager Yorkville Advisors...
Achiko Logo cropped.jpg
Achiko AG Appoints Toolbox Medical Innovations and NDA Group and Expands Advisory Board
November 02, 2020 08:52 ET | Achiko AG
Encouraging Initial Results to Date in Field Validation TrialsToolbox Medical Innovations Engaged for the Design of the Commercial Test KitNDA Group Engaged to Assist in Progress Towards CE...